Solid Biosciences Inc.SLDBNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.4%
5Y CAGR+16.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+21.4%/yr
vs +7.8%/yr prior
5Y CAGR
+16.7%/yr
Recent acceleration
Acceleration
+13.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $140.32M | +45.5% |
| 2024 | $96.43M | +25.9% |
| 2023 | $76.56M | -2.4% |
| 2022 | $78.42M | +33.5% |
| 2021 | $58.74M | -9.5% |
| 2020 | $64.88M | -31.5% |
| 2019 | $94.74M | +63.4% |
| 2018 | $57.97M | +45.3% |
| 2017 | $39.91M | +98.4% |
| 2016 | $20.12M | - |